BioSyent Inc. (OTCMKTS:BIOYF) Short Interest Up 21.4% in December

BioSyent Inc. (OTCMKTS:BIOYF) saw a significant increase in short interest in December. As of December 15th, there was short interest totalling 1,700 shares, an increase of 21.4% from the November 30th total of 1,400 shares. Based on an average daily volume of 7,300 shares, the days-to-cover ratio is presently 0.2 days.

BioSyent Price Performance

Shares of BIOYF stock traded up $0.54 on Tuesday, hitting $7.92. The stock had a trading volume of 100 shares, compared to its average volume of 2,316. The company has a fifty day moving average price of $8.05 and a two-hundred day moving average price of $7.77. BioSyent has a twelve month low of $5.93 and a twelve month high of $8.90.

BioSyent Cuts Dividend

The firm also recently announced a dividend, which was paid on Monday, December 16th. Investors of record on Monday, December 2nd were paid a dividend of $0.0322 per share. The ex-dividend date was Friday, November 29th. This represents a yield of 1.6%.

BioSyent Company Profile

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.